about clarmon main image


management iconAbout Clarmon


Advisory Board


Clarmon’s Board of Advisors plays a major role in ensuring unique access to valuable industry know-how, and provides significant assistance in building an extensive network of partners and clients.

Dr. Christopher Burgess

Chris is an internationally recognized expert in the qualification and validation of instrumentation and systems and the interpretation of data.  In addition he has extensive experience in quality systems design and development for the whole supply chain and has acted as a Qualified Person within the EU for more than 20 years. He has over 30 years experience in the pharmaceutical industry primarily with Glaxo in Quality Assurance and Analytical R &D. He holds MSc and PhD degrees from Loughborough University in Analytical Chemistry and is a Chartered Chemist (CChem), a Fellow of the Royal Society of Chemistry (RSC), a Chartered European Chemist (EurChem) and a Chartered Scientist (CSci) as well as a qualified ISO Guide 17025 assessor. He has published over 60 papers and books in analytical chemistry and analytical science.

Prof. Claude Nicolau, PhD

Claude is an International Leader in Cellular Biophysics. He is a Visiting Professor at Tufts University in Boston, MA, USA. Prior he was a Visiting Professor of Medicine at Harvard Medical School in Boston MA for 13 years. Professor Nicolau reported the world’s first gene transfer and expression in a live animal and has developed a number of widely used genetic techniques. Prof. Nicolau is working on an Immunotherapy for Alzheimer's disease as well as a new cancer related treatment using regulated oxygen delivery by red blood cells together with Prof. Jean-Marie Lehn, Ph.D. the winner of the Nobel Prize in Chemistry in 1987. He has published more than 210 scientific papers and has been awarded more than 30 patents to-date. Claude co- founded 3 Biotech companies in the US and Switzerland, which are all showing strong growth. At present he is Chief Scientific Officer of OxyPlus, Inc, Boston, MA and Strasbourg, France.

Lynette Lee

Lynette has worked as Pfizer’s Marketing Manager for APAC for 7 years. She has been the founding Director of Johnson and Johnson’s pharmaceutical and medical businesses in Singapore and some countries of Asia for 13 years. She was one of the founders of Oculex Asia Pharmaceuticals, a company which researched and developed an innovative drug delivery system. Oculex was sold to Allergan of the USA in a $230 Million cash transaction in late 2003. She has been Vice President of the Singapore Association of Pharmaceutical Industries for many years and a member of the Singapore Ministry of Health’s Drug Advisory committee. Mrs Lee is a pharmacist graduated from Sydney University, Australia.

Brian Vickers

Brian is a recognized senior executive in plant start-up and production, FDA pre-approval inspection, cGMP, validation and process re-engineering  and has over 30 years of experience in the pharmaceutical industry in primary manufacturing, including supervisory and management experience in API manufacture and quality assurance. His professional background contains roles of Start-Up and Quality Assurance Manager for Rhone Poulenc Rorer in UK, Start-Up Manager for Aventis Pharma in Singapore and Head of Validation and Compliance for M+W Zander.

Peter Russell

Peter is a Chartered Chemical Engineer with more than 30 years of pharmaceutical construction and validation experience from a long list of global director assignments at GSK and GlaxoWellcome including the role of Engineering Technical Director for GSK Primary Operations. He brings strong industry experience in the Design, Construction and Validation of GMP facilities.

Thomas Pinborg

Thomas is currently the head of CVM marketing for Novartis. Thomas is a highly experienced marketing executive with past assignments such as Regional Marketing Manager for EMEA at Novartis and Global Marketing Manager for the Vioxx product line at Merck Sharp & Dohme. Thomas has also been CEO for a medical information portal in early 2000.

Calvin Wang

Calvin is a highly experienced Lead Validation/Lead Project Engineer with extensive experience in the management of Projects in the fields of Engineering, Procurement, Construction and Commissioning & Qualification for Pharmaceutical, Oil & Gas, Petrol-Chemical and Semiconductor Industries. He is a member of the ISPE and has been working as Lead Validation Engineer in Asia, UK and Australia for Glaxosmithkline, Foster Wheeler, Schering-Plough and M+W Zander.

Siegfried Schmitt

Dr. Siegfried Schmitt is a chartered chemist and chartered scientist with 19 years experience as a production and quality assurance manager in the industry and as a consultant for several international consulting firms. His area of expertise covers pharmaceuticals, medical devices and especially computerised systems. He is a principal consultant with PAREXEL Consulting in the Strategic Compliance and Operational Performance Excellence team. Siegfried regularly publishes articles on scientific and business subjects and has written several books. He speaks on a variety of topics at international conferences and industry meetings.

about previewCompany Overview

Who we are?

What we do?

management previewManagement

Experienced managers steering us towards better results...

customers previewCustomers

Julphar, M+W Zander, LYNK, Biotechnologies Pte Ltd, StatConsult Dynalink...